UIH(SH:688271) Sou Hu Cai Jing·2025-12-25 12:48Core Viewpoint - The financial performance of United Imaging Healthcare (688271) shows significant growth in revenue and net profit for the first three quarters of 2025, indicating strong operational efficiency and market demand for its medical imaging and treatment solutions [2]. Financial Performance - For the first three quarters of 2025, the company reported a main revenue of 8.859 billion yuan, a year-on-year increase of 27.39% [2]. - The net profit attributable to shareholders reached 1.12 billion yuan, up 66.91% year-on-year [2]. - The non-recurring net profit was 1.053 billion yuan, reflecting a substantial increase of 126.94% year-on-year [2]. - In Q3 2025 alone, the company achieved a main revenue of 2.843 billion yuan, a remarkable rise of 75.41% year-on-year [2]. - The net profit for Q3 was 122 million yuan, showing a significant increase of 143.8% year-on-year [2]. - The non-recurring net profit for Q3 was 87.6141 million yuan, up 126.24% year-on-year [2]. - The company's debt ratio stands at 30.08%, with investment income of 606.847 million yuan and financial expenses of -438.233 million yuan [2]. - The gross profit margin is reported at 47.02% [2]. Market Activity - As of December 25, 2025, the stock price closed at 129.62 yuan, reflecting an increase of 2.59% [1]. - The trading volume was 48,400 lots, with a total transaction value of 619 million yuan [1]. - The net outflow of main funds was 12.5157 million yuan, accounting for 2.02% of the total transaction value [1]. - Retail investors showed a net inflow of 22.2543 million yuan, representing 3.59% of the total transaction value [1]. Analyst Ratings - In the last 90 days, 25 institutions provided ratings for the stock, with 18 buy ratings and 7 hold ratings [2]. - The average target price set by institutions over the past 90 days is 17.312 billion yuan [2].